Size Dependence Of Lateral Diffusion In Model Cell Membranes Using Fluorescently Labelled Probe Molecules

Abstract Not Available

Mobile NMR and MRI: developments and applications

This book will summarise recent hardware developments, highlight the challenges facing mobile and generally low-field NMR and MRI and describe various emerging applications - some of which have commercial interest

Estudios de Resonancia Magnética en Anemia de Hematies Falciformes

Magnetic Resonance applications to the study of Sickle Cell Disease are analyzed using classical procedures and Unilateral Magnetic Resonance. Hemoglobin and whole blood samples were obtained from healthy individual and patients with Sickle Cell Anemia to be used as samples. Classical pulse sequence as spin echo and inversion recovery were used in the experimental studies, the STEPR method was used for EPR spectrometric determinations. The results show the possibility of NMR methods to follow the molecular process causing the disease and allow us to present quantitative procedures to estimate the clinical state of the patients and the results of clinical options. We present the Unilateral Magnetic Resonance as a new method to study Sickle Cell disease considering its portability and new possibilities as new image method.En este trabajo se analizan diferentes aplicaciones de la Resonancia Magnética al estudio de la Anemia de Hematíes Falciformes, incluyendo métodos clásicos y la Resonancia Magnética Unilateral. Las muestras de hemoglobina y sangre total fueron obtenidas a partir de individuos saludables y pacientes con Anemia Drepanocítica. Secuencias de pulso clásicas como spin eco e inversión recuperación fueron utilizadas en los estudios experimentales, el método de STEPR fue utilizado para determinaciones espectrofotométricas de Resonancia Paramagnética Electrónica. Los resultados muestran la posibilidad de los métodos de Resonancia Magnética para estudiar el proceso molecular que causa esta enfermedad y nos permite presentar procedimientos cuantitativos para estimar el estado clínico del paciente y evaluar opciones terapéuticas. Presentamos la Resonancia Magnética Unilateral como un nuevo método para estudiar la Anemia Drepanocítica considerando su portabilidad y nuevas posibilidades como método de imagen

Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes

Background: Mutations in several genes predispose to colorectal cancer. Genetic testing for hereditary colorectal cancer syndromes was previously limited to single gene tests; thus, only a very limited number of genes were tested, and rarely those infrequently mutated in colorectal cancer. Next-generation sequencing technologies have made it possible to sequencing panels of genes known and suspected to influence colorectal cancer susceptibility. Methods: Targeted sequencing of 36 known or putative CRC susceptibility genes was conducted for 1231 CRC cases from five subsets: (1) Familial Colorectal Cancer Type X (n\ua0=\ua0153); (2) CRC unselected by tumor immunohistochemical or microsatellite stability testing (n\ua0=\ua0548); (3) young onset (ag

Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry

Although many loci have been associated with height in European ancestry populations, very few have been identified in African ancestry individuals. Furthermore, many of the known loci have yet to be generalized to and fine-mapped within a large-scale African ancestry sample. We performed sex-combined and sex-stratified meta-analyses in up to 52,764 individuals with height and genome-wide genotyping data from the African Ancestry Anthropometry Genetics Consortium (AAAGC). We additionally combined our African ancestry meta-analysis results with published European genome-wide association study (GWAS) data. In the African ancestry analyses, we identified three novel loci (SLC4A3, NCOA2, ECD/FAM149B1) in sex-combined results and two loci (CRB1, KLF6) in women only. In the African plus European sex-combined GWAS, we identified an additional three novel loci (RCCD1, G6PC3, CEP95) which were equally driven by AAAGC and European results. Among 39 genome-wide significant signals at known loci, conditioning index SNPs from European studies identified 20 secondary signals. Two of the 20 new secondary signals and none of the 8 novel loci had minor allele frequencies (MAF) \u3c 5%. Of 802 known European height signals, 643 displayed directionally consistent associations with height, of which 205 were nominally significant (p \u3c 0.05) in the African ancestry sex-combined sample. Furthermore, 148 of 241 loci contained ≤20 variants in the credible sets that jointly account for 99% of the posterior probability of driving the associations. In summary, trans-ethnic meta-analyses revealed novel signals and further improved fine-mapping of putative causal variants in loci shared between African and European ancestry populations

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry

<p>Genome-wide association studies (GWAS) have identified 36 loci associated with body mass index (BMI), predominantly in populations of European ancestry. We conducted a meta-analysis to examine the association of >3.2 million SNPs with BMI in 39,144 men and women of African ancestry and followed up the most significant associations in an additional 32,268 individuals of African ancestry. We identified one new locus at 5q33 (GALNT10, rs7708584, P = 3.4 x 10(-11)) and another at 7p15 when we included data from the GIANT consortium (MIR148A-NFE2L3, rs10261878, P = 1.2 x 10(-10)). We also found suggestive evidence of an association at a third locus at 6q16 in the African-ancestry sample (KLHL32, rs974417, P = 6.9 x 10(-8)). Thirty-two of the 36 previously established BMI variants showed directionally consistent effect estimates in our GWAS (binomial P = 9.7 x 10(-7)), five of which reached genome-wide significance. These findings provide strong support for shared BMI loci across populations, as well as for the utility of studying ancestrally diverse populations.</p>

Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

Abstract Autosomal genetic analyses of blood lipids have yielded key insights for coronary heart disease (CHD). However, X chromosome genetic variation is understudied for blood lipids in large sample sizes. We now analyze genetic and blood lipid data in a high-coverage whole X chromosome sequencing study of 65,322 multi-ancestry participants and perform replication among 456,893 European participants. Common alleles on chromosome Xq23 are strongly associated with reduced total cholesterol, LDL cholesterol, and triglycerides (min P = 8.5 × 10−72), with similar effects for males and females. Chromosome Xq23 lipid-lowering alleles are associated with reduced odds for CHD among 42,545 cases and 591,247 controls (P = 1.7 × 10−4), and reduced odds for diabetes mellitus type 2 among 54,095 cases and 573,885 controls (P = 1.4 × 10−5). Although we observe an association with increased BMI, waist-to-hip ratio adjusted for BMI is reduced, bioimpedance analyses indicate increased gluteofemoral fat, and abdominal MRI analyses indicate reduced visceral adiposity. Co-localization analyses strongly correlate increased CHRDL1 gene expression, particularly in adipose tissue, with reduced concentrations of blood lipids